Jielin Tang

机构：Chinese Academy of Medical Sciences & Peking Union Medical College · ORCID：0000-0002-4398-2927

发表论文 42 篇 · 总被引 598 次 · h-index 17

代表论文

• Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry (2023 · Nature Communications · 被引 48)
• A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro (2025 · Nature Communications · 被引 35)
• Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19 (2024 · Nature Communications · 被引 34)
• Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein (2024 · Signal Transduction and Targeted Therapy · 被引 28)
• Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies (2024 · Signal Transduction and Targeted Therapy · 被引 27)
• Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection (2023 · Nature Communications · 被引 26)